| 000 | 01904 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517215607.0 | ||
| 264 | 0 | _c20191021 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1540-1413 | ||
| 024 | 7 |
_a10.6004/jnccn.2018.0042 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarker, Christopher A | |
| 245 | 0 | 0 |
_aNew NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. _h[electronic resource] |
| 260 |
_bJournal of the National Comprehensive Cancer Network : JNCCN _c05 2018 |
||
| 300 |
_a646-650 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBrachytherapy _xmethods |
| 650 | 0 | 4 |
_aCostimulatory and Inhibitory T-Cell Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEye Enucleation _xmethods |
| 650 | 0 | 4 |
_aLiver Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aLymphatic Metastasis _xpathology |
| 650 | 0 | 4 |
_aMedical Oncology _xstandards |
| 650 | 0 | 4 |
_aMelanoma _xgenetics |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xgenetics |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSkin Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aSocieties, Medical _xstandards |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aUveal Neoplasms _xgenetics |
| 650 | 0 | 4 | _aUveal Melanoma |
| 700 | 1 | _aSalama, April K | |
| 773 | 0 |
_tJournal of the National Comprehensive Cancer Network : JNCCN _gvol. 16 _gno. 5S _gp. 646-650 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.6004/jnccn.2018.0042 _zAvailable from publisher's website |
| 999 |
_c28414286 _d28414286 |
||